The Therapeutic Goods Administration (TGA) has rescheduled both MDMA and Psilocybin from Schedule 9 ‘prohibited substances’ to Schedule 8 ‘controlled drugs’.
From 1st of July this year, certain Psychiatrists will be able to prescribe the drugs in their treatments, an outcome that has been received with both praise and caution from those within the psychology and pharmacology sector.
Produced By: Madhuraa Prakash
Featured In Story: Professor Chris Langmead, Deputy Director Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences
First aired on The Wire, Wednesday 8 February 2023